XML 43 R28.htm IDEA: XBRL DOCUMENT
v3.21.2

UNAUDITED QUARTERLY DATA | 12 Months Ended
--- | ---
Jun. 30, 2021
Quarterly Financial Data [Abstract] |
UNAUDITED QUARTERLY DATA | UNAUDITED QUARTERLY DATA
Dollars in millions, except per share data | Quarters Ended |  |
| September 30 |  | December 31 |  | March 31 |  | June 30 |  | Full Year
Fiscal year ended June 30, 2021 |  |  |  |  |  |  |  |  |
Net sales | $ | 1,916 |  |  | $ | 1,842 |  |  | $ | 1,781 |  |  | $ | 1,802 |  |  | $ | 7,341 |
Cost of products sold | $ | 996 |  |  | $ | 1,005 |  |  | $ | 1,007 |  |  | $ | 1,134 |  |  | $ | 4,142 |
Net earnings (losses) (1) | $ | 417 |  |  | $ | 261 |  |  | $ | (59) |  |  | $ | 100 |  |  | $ | 719 |
Net earnings (losses) attributable to Clorox (1) | $ | 415 |  |  | $ | 259 |  |  | $ | (61) |  |  | $ | 97 |  |  | $ | 710 |
Net earnings (losses) per share attributable to Clorox: |  |  |  |  |  |  |  |  |
Basic net earnings (losses) per share | $ | 3.28 |  |  | $ | 2.06 |  |  | $ | (0.49) |  |  | $ | 0.79 |  |  | $ | 5.66 |
Diluted net earnings (losses) per share | $ | 3.22 |  |  | $ | 2.03 |  |  | $ | (0.49) |  |  | $ | 0.78 |  |  | $ | 5.58 |
Dividends declared per share | $ | 1.11 |  |  | $ | 1.11 |  |  | $ | 1.11 |  |  | $ | 1.16 |  |  | $ | 4.49 |
Fiscal year ended June 30, 2020 |  |  |  |  |  |  |  |  |
Net sales | $ | 1,506 |  |  | $ | 1,449 |  |  | $ | 1,783 |  |  | $ | 1,983 |  |  | $ | 6,721 |
Cost of products sold | $ | 843 |  |  | $ | 810 |  |  | $ | 951 |  |  | $ | 1,054 |  |  | $ | 3,658 |
Net earnings (losses) | $ | 203 |  |  | $ | 185 |  |  | $ | 241 |  |  | $ | 310 |  |  | $ | 939 |
Net earnings attributable to Clorox | $ | 203 |  |  | $ | 185 |  |  | $ | 241 |  |  | $ | 310 |  |  | $ | 939 |
Net earnings per share attributable to Clorox: |  |  |  |  |  |  |  |  |
Basic net earnings per share | $ | 1.61 |  |  | $ | 1.48 |  |  | $ | 1.92 |  |  | $ | 2.45 |  |  | $ | 7.46 |
Diluted net earnings per share | $ | 1.59 |  |  | $ | 1.46 |  |  | $ | 1.89 |  |  | $ | 2.41 |  |  | $ | 7.36 |
Dividends declared per share | $ | 1.06 |  |  | $ | 1.06 |  |  | $ | 1.06 |  |  | $ | 1.11 |  |  | $ | 4.29 |
(1) Fiscal year 2021 net earnings and net earnings attributable to Clorox includes impairment charges recorded in the quarter ended March 31, 2021 within the VMS reporting unit of $329, of which $228, $86, and $15 related to goodwill, certain indefinite-lived trademarks and other assets, respectively. FIVE-YEAR FINANCIAL SUMMARY The Clorox Company
| Years ended June 30
Dollars in millions, except per share data | 2021 (2) |  | 2020 |  | 2019 |  | 2018 |  | 2017
OPERATIONS |  |  |  |  |  |  |  |  |
Net sales | $ | 7,341 |  |  | $ | 6,721 |  |  | $ | 6,214 |  |  | $ | 6,124 |  |  | $ | 5,973 |
Gross profit | 3,199 |  |  | $ | 3,063 |  |  | $ | 2,728 |  |  | $ | 2,675 |  |  | $ | 2,671 |
Earnings from continuing operations | $ | 719 |  |  | $ | 939 |  |  | $ | 820 |  |  | $ | 823 |  |  | $ | 703 |
(Losses) earnings from discontinued operations, net of tax | — |  |  | — |  |  | — |  |  | — |  |  | (2) |
Net earnings | $ | 719 |  |  | $ | 939 |  |  | $ | 820 |  |  | $ | 823 |  |  | $ | 701 |
Net earnings attributable to Clorox | $ | 710 |  |  | $ | 939 |  |  | $ | 820 |  |  | $ | 823 |  |  | $ | 701 |
COMMON STOCK |  |  |  |  |  |  |  |  |
Net earnings per share attributable to Clorox: |  |  |  |  |  |  |  |  |
Continuing operations |  |  |  |  |  |  |  |  |
Basic net earnings per share | $ | 5.66 |  |  | $ | 7.46 |  |  | $ | 6.42 |  |  | $ | 6.37 |  |  | $ | 5.45 |
Diluted net earnings per share | 5.58 |  |  | 7.36 |  |  | 6.32 |  |  | 6.26 |  |  | 5.35 |
Dividends declared per share | 4.49 |  |  | 4.29 |  |  | 3.94 |  |  | 3.60 |  |  | 3.24 |
| As of June 30
Dollars in millions | 2021 |  | 2020 |  | 2019 |  | 2018 |  | 2017
OTHER DATA |  |  |  |  |  |  |  |  |
Total assets (1) | $ | 6,334 |  |  | $ | 6,213 |  |  | $ | 5,116 |  |  | $ | 5,060 |  |  | $ | 4,573 |
Long-term debt | 2,484 |  |  | 2,780 |  |  | 2,287 |  |  | 2,284 |  |  | 1,391 |
(1) As a result of adopting ASU No. 2016-02, “Leases (ASC 842),” the Company has included operating right-of-use assets within Total assets as of June 30, 2020. See Note 1 for more information. (2) Fiscal year 2021 net earnings and net earnings attributable to Clorox includes impairment charges recorded within the VMS reporting unit of $329, of which $228, $86, and $15 related to goodwill, certain indefinite-lived trademarks and other assets, respectively.

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialDataAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -URI http://asc.fasb.org/topic&trid=2126967 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 1B -URI http://asc.fasb.org/extlink&oid=124502072&loc=SL124452896-108306 + Details
Name: | us-gaap_QuarterlyFinancialInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration